Back

Gadobutrol enhanced CMR to detect significant coronary artery disease defined by quantitative coronary angiography. Results from two blinded phase III clinical trials

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Innovations in CMR imaging of coronary artery disease Stress Cardiac Magnetic Resonance (CMR) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Andrew Arai

National Institutes of Health (NIH), Bethesda (United States of America)

3 More presentations in this session

Presentation thumbnail
State of the Art - CMR imaging of coronary artery disease
Professor E. Nagel (Frankfurt, DE)
Slides Video
Presentation thumbnail
Systematic review and meta-analysis on the diagnostic accuracy for the detection of relevant coronary artery stenosis of vasodilator myocardial perfusion CMR and dobutamine stress echocardiography
Doctor S. Haberkorn (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Ischemic burden by vasodilator stress CMR predicts long-term all-cause death and the effect of revascularization in patients with known or suspected stable ischemic heart disease
Doctor V. Marcos Garces (Valencia, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Innovations in CMR imaging of coronary artery disease

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Magnetic resonance imaging is the way to go for risk assessment
thumbnail
Congress Presentation
Practical opportunities to optimise outcomes in stress cardiac MR
thumbnail
Congress Presentation
CMR in the chronic coronary syndrome guidelines

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources